Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 21;7(18):5519-5535.
doi: 10.1039/d5na00365b. eCollection 2025 Sep 10.

Evaluating the impact of bioinspired counterion inclusion on silk nanoparticle physicochemical attributes and physical stability

Affiliations
Free PMC article

Evaluating the impact of bioinspired counterion inclusion on silk nanoparticle physicochemical attributes and physical stability

Napaporn Roamcharern et al. Nanoscale Adv. .
Free PMC article

Abstract

Silk fibroin is a promising material for nanocarrier-based drug delivery applications due to its biocompatibility, biodegradability, and mechanical properties, which can be fine-tuned through processing conditions. In this study, we explore the impact of Ca2+ and K+ inclusion on the morphology of silk nanoparticles and evaluate the short- and long-term stability of silk nanoparticles formed by antisolvent precipitation in deionized water and sodium phosphate buffer. Using advanced electric asymmetric flow field-flow fractionation multiplexed with online detectors (EAF4-UV-MALS-DLS) and orthogonal analytics (DLS, ELS, NTA, FE-SEM), we analyze the physicochemical attributes of silk nanoparticles. We find significant differences in nanoparticle architecture and stability in different buffers, with notable differences in particle size (R g and R h), charge, and shape measured over 56 days. Notably, nanoparticles formulated with 0.7 mg Ca2+ and 1.1 mg K+ maintained superior physicochemical stability, making them promising candidates for future nanocarrier-based applications.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. AAPS PharmSciTech. 2020 Apr 26;21(4):122 - PubMed
    1. Biochemistry. 1984 Dec 4;23(25):5912-23 - PubMed
    1. Annu Rev Anal Chem (Palo Alto Calif). 2021 Jun 5;14(1):257-279 - PubMed
    1. Chem Soc Rev. 2017 Jul 17;46(14):4218-4244 - PubMed
    1. Adv Healthc Mater. 2019 Jan;8(1):e1800465 - PubMed

LinkOut - more resources